Metabolic, Cardiac & Pulmonary
Type 2 Diabetes
Metabolic disease involving insulin resistance.
About this condition
Research is exploring cellular therapies for metabolic health. Lifestyle and your prescribed medication remain the foundation.
How we approach it
These conditions require coordination with your specialists. Protocols are supportive and only offered to medically stable patients.
Therapies we may consider
How to prepare
- •Gather your records: diagnosis letters, recent lab results, imaging reports (MRI, X-ray, CT) and a medication list.
- •Keep taking prescribed medication — we never ask you to stop treatment from your own doctor.
- •Ask your specialist whether they are willing to share notes with our physicians; coordinated care is safer.
- •Write down your main goals and current symptoms (for example, pain on a 0–10 scale or walking distance) so we can measure change honestly.
- •Plan your trip: most programs need 2–5 days in Los Cabos, and you should avoid long flights for 24 hours after joint procedures if possible.
Possible side effects
Depends on the therapy your physician recommends. Most are mild and short-lived.
Mesenchymal Stem Cells
- · Mild fatigue, low-grade fever or chills in the first 24–48 hours after infusion
- · Headache or mild nausea
- · Soreness, swelling or stiffness at the injection site for a few days (joint injections)
- · Bruising at the IV site
Peptide & NAD+ Protocols
- · During NAD+ infusion: chest tightness, flushing, nausea, cramping or headache — these usually settle quickly when the drip is slowed
- · Injection-site redness for peptides
- · Mild fatigue
Selected published research
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Yoshino M et al., Science, 2021
A small randomised trial showing improved insulin sensitivity.
Allogeneic MSCs in heart failure (POSEIDON and related trials)
Hare JM et al., JAMA, 2012
Cell therapy was safe, with some improvements in heart remodelling; larger trials have shown mixed results.
A placebo-controlled randomized trial of MSCs in COPD
Weiss DJ et al., Chest, 2013
MSC infusions were safe and lowered an inflammation marker, though lung function did not change significantly.
Links open PubMed or the original source. Study results do not guarantee individual outcomes.
What the evidence says
Therapies are used as supportive care alongside — never instead of — your existing medical treatment.
We do not promise cures or specific outcomes. Read our safety & eligibility page.
Wondering if you're a candidate?
A physician will review your records and give you an honest answer.
Book a Consultation